Astrazeneca AZN
NYSE AZN
$156.91 -0.77 (-0.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Consolidated Net Income (2009 - 2026)

Updated

Astrazeneca (AZN) reported Consolidated Net Income of $2.51 billion for Q2 2026, up 2.5% from $2.45 billion a year earlier but down 18.6% from the prior quarter.

Analysis

Astrazeneca (AZN) Consolidated Net Income (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Astrazeneca's Consolidated Net Income came in at $10.45 billion, up 25.9% year-over-year; for FY2025, it came in at $10.23 billion, up 45.3% from FY2024.

  • Consolidated Net Income has increased for three consecutive years, with a five-year compound annual growth rate of 26.6% (FY2020 to FY2025).
  • By year, Consolidated Net Income came in at $7.04 billion in FY2024 (+18.1%), $5.96 billion in FY2023 (+81.0%), $3.29 billion in FY2022 and $115 million in FY2021 (-96.3%).
  • Five-year quarterly Consolidated Net Income spans a low of -$1.65 billion in Q3 2021 and a high of $3.08 billion in Q1 2026.
  • Year over year, Consolidated Net Income has now increased in each of the last 11 quarters, with growth averaging 32.7% over the last eight quarters.
  • The high point for year-over-year Consolidated Net Income in five years was Q2 2023 (growth of 405.6%); the low point was Q1 2022 (a decline of 75.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.08 billion (Q1 2026), $2.33 billion (Q4 2025) and $2.54 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.62 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.51 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -237.00 Mn
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.51 Bn
Mar 31, 2026 3.08 Bn
Dec 31, 2025 2.33 Bn
Sep 30, 2025 2.54 Bn
Jun 30, 2025 2.45 Bn
Mar 31, 2025 2.92 Bn
Dec 31, 2024 1.50 Bn
Sep 30, 2024 1.43 Bn
Jun 30, 2024 1.93 Bn
Mar 31, 2024 2.18 Bn
Dec 31, 2023 959.00 Mn
Sep 30, 2023 1.38 Bn
Jun 30, 2023 1.82 Bn
Mar 31, 2023 1.80 Bn
Dec 31, 2022 902.00 Mn
Sep 30, 2022 1.64 Bn
Jun 30, 2022 360.00 Mn
Mar 31, 2022 388.00 Mn
Dec 31, 2021 -346.00 Mn
Sep 30, 2021 -1.65 Bn
API Access

Astrazeneca Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=AZN&period=max&api_key=YOUR_API_KEY